Drug Type Biological products |
Synonyms- |
Target |
Action modulators |
Mechanism ADGRG1 modulators(adhesion G protein-coupled receptor G1 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | United States | 08 Apr 2022 |